ClinicalTrials.gg
Drug

ZD4054 clinical trials

Also written Zibotentan and ZD4054.

studies test it
32
open now
0
in phase 3
4
first study started
2003

How each study uses ZD4054 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

ZD4054 (Zibotentan)
2
ZD4054 15 mg
2
ZD4054 10 mg
2

Development codes

ZD4054
13

Other names

Zibotentan
22

In one entry with another drug

Given together, or one or the other

Zibotentan/Dapagliflozin
2

Studies by the year they started

31 studies that test it; most in 2008 (7)

Studies that test ZD4054, by start year
YearStudies
20031
20041
20061
20071
20087
20094
20102
20131
20141
20191
20213
20223
20231
20242
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
16
Phase 3
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 9

AstraZeneca (23) · Cardiff University (2) · University Medical Center Groningen (1) · NHS Greater Glasgow and Clyde (1) · University College, London (1) · University of Virginia (1) · University of Wisconsin, Madison (1) · Aarhus University Hospital (1)

Often tested with

Tested in the same studies.

Dapagliflozin (7) · FOLFIRI Regimen (1) · Fluorouracil (1) · Irinotecan (1) · Leucovorin (1) · Midazolam (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test ZD4054, phase 3 first.

Studies

Open first, then newest update. How each study uses ZD4054 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 32

See all 32 studies that test ZD4054 →

Given beside what is tested · 1 — ZD4054 is usual care or a partner of the new treatment